EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Australian vaccine preventable disease epidemiological review series: Pertussis, 2013–2018

Kushani S Marshall, Helen E Quinn, Alexis J Pillsbury, Julia E Maguire, Robyn M Lucas, Aditi Dey, Frank H Beard, Kristine K Macartney, Peter B McIntyre

Communicable Diseases Intelligence · 27.01.2022 · 46

DOI: 10.33321/cdi.2022.46.3 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Communicable Diseases Intelligence, online erschienen am 27.01.2022. Verfasst von Kushani S Marshall und 8 weiteren Autor:innen. Beteiligte Einrichtung: National Centre for Immunisation Research and Surveillance, Westmead, New South Wales, Australia. Hauptthemen laut MEDLINE: Vaccine-Preventable Diseases, Whooping Cough. Die Arbeit wurde bisher 14-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Significant recent changes in Australian pertussis immunisation policy include the progressive introduction of funded pertussis immunisation programs for pregnant women, from late 2014 to mid-2015 at jurisdictional level and then under the National Immunisation Program from July 2018, and reintroduction of the 18-month booster dose in 2016. This study analyses pertussis notification, hospitalisation, and mortality data from 2013 to 2018 in the context of trends since 1995.

Methods

This study used data from the National Notifiable Diseases Surveillance System, the National Hospital Morbidity Database, and the Australian Coordinating Registry, for descriptive analysis of pertussis notifications, hospitalisations and deaths in Australia by Aboriginal and Torres Strait Islander (Indigenous) status from 2013 to 2018, examining trends between 1995 and 2012 at both the national and jurisdictional level. Incidence rate ratios (IRR) were utilised to compare pertussis incidence in infants aged < 2 months and 6–11 months for each year from the 2015–2018 (post-maternal-vaccination) period against the 2010–2013 (pre-maternal-vaccination) period. Results and Discussion Annual national all-age incidence of pertussis notifications between 2013 and 2018 was 63.6 per 100,000 population, 40% less than between 2006 and 2012. Between 2016 and 2018, infants aged < 2 months had the lowest notification rates of age groups < 5 years old, with the highest notification rates in pre-adolescents aged 9–11 years. Compared with the baseline period (2010–2013), the IRR for infants aged < 2 months decreased in each year during the post-maternal-vaccination period from 0.4 (95% confidence interval [95% CI]: 0.3–0.5) in 2015 to 0.1 (95% CI: 0.1–0.2) in 2018. For infants aged 6–11 months, the IRR was 0.9 (95% CI: 0.8–1.0) in 2015, 1.1 (95% CI: 1.0–1.2) in 2016 and declined to 0.7 (95% CI: 0.6–0.8) in 2017 and 2018. Notification and hospitalisation rates in Indigenous children were 3–8 times as high as rates in non-Indigenous children across all age groups < 5 years old.

Conclusion

Pertussis remains the second most frequently notified vaccine preventable disease in Australia, after influenza, but dramatic decreases in incidence have been observed in infants too young to receive any doses of pertussis-containing vaccine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vaccine-Preventable DiseasesWhooping CoughAdolescentAustraliaChildChild, PreschoolFemaleHumansImmunization ProgramsInfantPertussis VaccinePregnancyAustralian Aboriginal and Torres Strait Islander Peoples

Stichwörter der Autor:innen

Pertussisdisease surveillanceepidemiologyimmunisationvaccine preventable disease

Substanzen

Pertussis Vaccine

Autor:innen und Institutionen

  • National Centre for Immunisation Research and Surveillance, Westmead, New South Wales, Australia.
  • The Australian National University, Canberra, Australian Capital Territory, Australia.
  • The University of Sydney, New South Wales, Australia.
  • The University of Otago, Dunedin, New Zealand.

Zitieren

APA

Marshall, K. S., Quinn, H. E., Pillsbury, A. J., Maguire, J. E., Lucas, R. M., Dey, A., Beard, F. H., Macartney, K. K., & McIntyre, P. B. (2022). Australian vaccine preventable disease epidemiological review series: Pertussis, 2013–2018. Communicable Diseases Intelligence, 46. https://doi.org/10.33321/cdi.2022.46.3

Vancouver

Marshall KS, Quinn HE, Pillsbury AJ, Maguire JE, Lucas RM, Dey A, et al. Australian vaccine preventable disease epidemiological review series: Pertussis, 2013–2018. Communicable Diseases Intelligence. 2022;46. doi:10.33321/cdi.2022.46.3

BibTeX
@article{Marshall2022,
  author = {Marshall, Kushani S and Quinn, Helen E and Pillsbury, Alexis J and Maguire, Julia E and Lucas, Robyn M and Dey, Aditi and Beard, Frank H and Macartney, Kristine K and McIntyre, Peter B},
  title = {Australian vaccine preventable disease epidemiological review series: Pertussis, 2013–2018},
  journal = {Communicable Diseases Intelligence},
  year = {2022},
  volume = {46},
  doi = {10.33321/cdi.2022.46.3}
}
Kostenlos starten →